SciClone Pharmaceuticals, Inc.
Develops and markets products targeted for treatment of cancer and diseases such as hepatitis B and C, cystic fibrosis and immune system disorders. Based in San Mateo, California. (Nasdaq: SCLN).
BioMarin Pharmaceutical Inc.
Researches and develops carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases or conditions. (Nasdaq: BMRN).
Spring Bank Technologies, Inc.
Development of novel anti-viral therapies, including hepatitis B in Milford, Massachusetts.
http://home.townisp.com/~nand12/index.html
http://home.townisp.com/~nand12/index.html
Archemix Corp.
Company developing therapeutics of aptamers, for the prevention and treatment of chronic and acute disease. Includes overview of technology and commercial potential, careers and contacts in Cambridge, Massachusetts.
Oxxon Therapeutics
Developing a portfolio of immunotherapeutics for infectious diseases and cancer using its proprietary boosting regime. Includes overview of technology, publications and corporate profile, with contacts in Oxford, England and Boston, Massachusetts.
Dongbao Enterprise Group Co., Ltd.
Conglomerate industrial group, with more than 20 subsidiaries, engaged in the field of pharmaceutical production and manufacturers of recombinants, especially human insulin in Shanghai, China.
http://www.dongbao.com/en/access/index.htm
http://www.dongbao.com/en/access/index.htm
Shantha Biotechnics Pvt. Ltd.
Offering rDNA derived streptokinase, human inteferon alpha of type 2b, and hepatitis-B vaccine, with developments in endocrine, growth factors, immunotherapy, vaccine and diagnostics. Based in Hyderabad, India.
http://www.shanthabiotech.com/
http://www.shanthabiotech.com/
Octagen Corp.
Privately held company developing therapies for hemophilia and other genetic disorders, using recombinant Factor VIII and gene therapy. Includes clinical trial status, licensing, corporate profile and contacts in Bala Cynwyd, Pennsylvania.
Aphios Corp.
Developing natural therapeutics, with a focus on infectious diseases, cancer and quality-of-life medicines. Overview of extraction and nanoscale technologies, product pipeline and profile of company in Woburn, Massachusetts.
Versicor, Inc.
Biopharmaceutical company focused on the marketing, development and discovery of pharmaceutical products for the treatment of bacterial and fungal infections. (Nasdaq: VERS).
Vertex Pharmaceuticals Incorporated
Discovers, develops and sells small molecule pharmaceuticals for treatment of diseases, such as HIV infection and AIDS, cancer, hepatitis C and diabetic neuropathy. (Nasdaq: VRTX).
Xenova Group plc
Holding company with subsidiaries which discover and develop small molecule drugs derived from naturally occurring micro-organisms, primarily for the treatment of cancer. Contacts in Slough and Cambridge, England.
Pharming
Offers novel platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation. Includes preclinical status of products, and details of corporation in Leiden, The Netherlands.
Euroscreen
Drug discovery company focused on custom screening, luminescence testing and functional screening, interacting with G protein-coupled receptors. Offers custom cloning and production in Gosselies, Belgium.
http://www.euroscreen-discovery.com/
http://www.euroscreen-discovery.com/
ZymoGenetics, Inc.
Discovery, development and commercialization of therapeutic proteins for the prevention and treatment of human diseases. Includes product pipeline, news on clinical trials and profile of company in Seattle, Washington.
Novacta Biosystems Ltd.
Drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. Introduces biotransformation technology, lead compounds, key personnel in Norwich, England.
Biopro Pharmaceutical Inc.
Research and marketing, with focus on cancer and aging products for Asia, with offices in Mill Valley, California and Taipei, Taiwan.
BioSphings AG
Innovating viral phospholipase inhibitor to prevent expression of Herpes specific genes, and intracellular viral antigens, and drug inducing death of tumor cells and autoreactive immune cells, in multiple sclerosis, rheumatism, and Crohn's disease. Based in Leverkusen, Germany.
Rib-X Pharmaceuticals Inc.
Structure-based drug design start-up, specializing in the ribosome as a target, and bacterial antibiotic resistance. Includes mechanisms of action, glossary, careers, corporate news and contacts and directions in New Haven, Connecticut.
Gene Products, LLC.
Company offering gene synthesis, site-specific mutagenesis, expression optimization, prospective drug target validation services. Based in Dallas, Texas.
Intra-Cellular Therapies, Inc.
Developing novel drugs against targets inside nerve cells to treat CNS disorders. Includes therapeutic projects, target biochemistry, corporate data and contacts in New York, United States.
http://www.intracellulartherapies.com/
http://www.intracellulartherapies.com/
Hemobiotech Inc.
Developer of blood substitute, aiming to address intrinsic hemoglobin toxicity. Introduction to company and their work, with form to contact Dallas, Texas.
Anhui Anke Biotechnology Co., Ltd.
Specializes in developing and manufacturing genetically engineered drugs; somatropin, interferon, including monoclonal affinity columns for recombinant subtypes, kits for fertility and sperm detection, in Hefei, China.
AplaGen Biopharmaceuticals
Development of cytokine analogs for cancer therapy, peptides for contraception, diagnosis and treatment of infertility. Includes introduction to technology, projects, key staff, and contacts for careers in Baesweiler, Germany.
Nephros Therapeutics, Inc.
Specialist in the design, development, and marketing of human cell replacement therapy systems, targeting inflammatory disease. Includes directions to research labs at Ann Arbor, Michigan, and corporate offices in Lincoln, Rhode Island.
http://www.nephrostherapeutics.com/
http://www.nephrostherapeutics.com/
Mixture Sciences, Inc.
A privately held company that specializes in research for treatment of HIV/AIDS, cancer, diabetes, multiple sclerosis, and infectious diseases, including Lyme Disease. Lists research projects and procedures.
http://www.mixturesciences.com/
http://www.mixturesciences.com/
Sierra Sciences Inc.
Developing drugs and therapies to reverse the effects of human aging by focusing on preserving the length of telomeres, to keep them more resilient. Careers in Reno, Nevada.
Pharma 21
Doing research and development for products in the treatment of brain and spinal cord damage. Lists current projects and how the drugs supposed to work.
XOMA
Development and manufacturing of recombinant proteins and peptides, primarily those derived from the host-defense protein BPI, for manufacturing biopharmaceuticals.
Vical, Inc. (VICL)
Developing gene-based treatments for cancer and infectious disease vaccines. Uses naked DNA technology and proprietary lipids to deliver genes into cells in the body.
Texas Biotechnology Corporation
Dedicated to the discovery, design, and development of new pharmaceutical compounds to treat vascular disease.
Myogen, Inc.
Develops therapeutic drugs to treat heart failure using expertise in molecular cardiology and a human heart tissue bank. Includes product pipeline, research overview, careers, contacts and directions in Westminster, Colorado.
Modular Genetics, Inc.
Supporting basic research, drug design, drug screening and chemical synthesis.
http://www.modulargenetics.com/
http://www.modulargenetics.com/
Morphochem
Focuses on finding therapeutic agents to treat diseases. Particular emphasis is on protein to protein interactions.
Millennium Pharmaceuticals, Inc.
Uses genomics to develop therapeutic drugs.
Lybradyn: Microbial Natural Products
Focused on discovering and developing natural products from living organisms to serve the pharmaceutical and fine chemical industries. Includes explanation of the procedures used in collecting the data.
GlycoTech Corporation
Research glycobiology company developing diagnostics and therapeutics for cancer and inflammatory diseases based on the interaction of glycoconjugates and their receptors.
Genfit
Focused on gene regulation and drug discovery strategies. Develops new drugs addressing diseases, such as arteriosclerosis, obesity, diabetes, inflammatory diseases. Based in Europe.
Generex Biotechnology
Developed a proprietary technology to orally administer large molecule drugs. These drugs include proteins, peptides, monoclonal antibodies, hormones and vaccines.
ConjuChem, Inc.
Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. Includes technology overview, research pipeline, partnerships, investment news, profiles of key staff in Montreal, Canada.
Cue Biotech Inc.
Company focusing on G-protein coupled receptor signaling as targets for therapeutic products. Includes corporate data, partnering and technology overviews, with media resources, list of publications, and opportunities in Chicago, Illinois.
ImmunoGen, Inc.
Called Tumor-Activated Prodrugs (TAPs), Products are small molecule anticancer agents with high potency and reduced toxicity.
BioRexis Pharmaceutical Corp.
Company with proprietary protein technology for carrier to enhance half-life and efficacy, fused peptide in therapeutic applications, and yeast host cell expression systems for production. Opportunities and contacts in King of Prussia, Pennsylvania.
Pharmos Corporation
Develops and commercializes products for the central nervous system (CNS), neurological, ophthalmic and other healthcare markets.
GenPhar
Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and contact information.